Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Junghans

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Nucleic Acids Research|October 12, 2000
Amplification of IgG VH and VL (Fab) from single human plasma cells and B cellsJ A Coronella, P Telleman, T D Truong, et al.
Biotechniques|June 1, 1993
An advanced solid support for immunoassays and other affinity applicationsD E Schmidt, T L Brooks, S Mhatre, et al.
Neoplasia (New York, N.Y.)|February 24, 2001
Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptorsC O Yun, K F Nolan, E J Beecham, et al.
Nature|June 1, 1989
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinV K Chaudhary, C Queen, R P Junghans, et al.
Cancer Research|November 3, 2001
Evidence for an antigen-driven humoral immune response in medullary ductal breast cancerJ A Coronella, P Telleman, G A Kingsbury, et al.
Cancer Research|March 1, 1990
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disordersR P Junghans, T A Waldmann, N F Landolfi, et al.
Cancer Gene Therapy|May 21, 2016
Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastasesM Thorn, P Guha, M Cunetta, et al.
Journal of Clinical Immunology|November 1, 1990
Lymphokine receptor-directed therapy: a model of immune interventionT A Waldmann, A Grant, C Tendler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cellsY Akamatsu, J C Murphy, K F Nolan, et al.
Cancer Research|December 1, 1993
Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapyR P Junghans, D Dobbs, M W Brechbiel, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Nucleic Acids Research|October 12, 2000
Amplification of IgG VH and VL (Fab) from single human plasma cells and B cellsJ A Coronella, P Telleman, T D Truong, et al.
Biotechniques|June 1, 1993
An advanced solid support for immunoassays and other affinity applicationsD E Schmidt, T L Brooks, S Mhatre, et al.
Neoplasia (New York, N.Y.)|February 24, 2001
Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptorsC O Yun, K F Nolan, E J Beecham, et al.
Nature|June 1, 1989
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinV K Chaudhary, C Queen, R P Junghans, et al.
Cancer Research|November 3, 2001
Evidence for an antigen-driven humoral immune response in medullary ductal breast cancerJ A Coronella, P Telleman, G A Kingsbury, et al.
Cancer Research|March 1, 1990
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disordersR P Junghans, T A Waldmann, N F Landolfi, et al.
Cancer Gene Therapy|May 21, 2016
Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastasesM Thorn, P Guha, M Cunetta, et al.
Journal of Clinical Immunology|November 1, 1990
Lymphokine receptor-directed therapy: a model of immune interventionT A Waldmann, A Grant, C Tendler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cellsY Akamatsu, J C Murphy, K F Nolan, et al.
Cancer Research|December 1, 1993
Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapyR P Junghans, D Dobbs, M W Brechbiel, et al.
Pageof 7